About Rapid Test Manufacturer, in Vitro Diagnostics, Drugs of Abu

Production Capacity

Export Year: 2007-03-01
Main Markets: North America, South America, Eastern Europe, Southeast Asia, Africa, Oceania, Mid East, Eastern Asia, Western Europe
R&D Capacity: OEM, Own Brand()
Factory Address: 90-94 Tianfeng Road, Jimei North Industrial Park, Xiamen, Fujian, China
No. of R&D Staff: 11-20 People
Terms of Payment: LC, T/T, D/P, PayPal, Western Union, Small-amount payment, Money Gram
Average Lead Time: Peak Season Lead Time: within 15 workdays, Off Season Lead Time: within 15 workdays
Export Percentage: 41%~50%
Import & Export Mode: Have Own Export License
Annual Export Revenue: >100 million USD
No. of Production Lines: 3
Number of Foreign Trading Staff: 4~10 People
International Commercial Terms(Incoterms): FOB, CFR, CIF, FAS, DDP, DAP, CIP, CPT, FCA, EXW

Trade terms

Peak-season Lead Time: within 15 workdays, Off Season Lead Time: within 15 workdays

Management certification

GMP, ISO 13485

Capabilities

Audited Supplier

Main markets

North America, South America, Eastern Europe, Southeast Asia, Africa, Oceania, Mid East, Eastern Asia, Western Europe

Main products

Rapid Test, in Vitro Diagnostics, Drugs of Abuse, HIV, Syphilis, Doa, Hbsag, Troponin I, Malaria, Dengue, More, Company Introduction, Trade Capacity, Production Capacity, Boson Biotech Co., Ltd., as a specialist of in vitro diagnostic kits field, we develop and manufacture high-quality point of care and other immunoassay kits for worldwide market., Our 10, 000 square meter facility is operated strictly under ISO 13485: 2016 and GMP guidelines. We combine the technological, material and labor resources of China and US to develop, manufacture and supply high ..., Boson Biotech Co., Ltd., as a specialist of in vitro diagnostic kits field, we develop and manufacture high-quality point of care and other immunoassay kits for worldwide market., Our 10, 000 square meter facility is operated strictly under ISO 13485: 2016 and GMP guidelines. We combine the technological, material and labor resources of China and US to develop, manufacture and supply high quality in vitro diagnostic products efficiently and cost effectively. Currently, we are offering product lines of rapid tests, CLIA, ELISA and raw materials. These product lines provide the immunoassays in various formats to detect cardiac markers, drugs of abuse, fertility hormones, infectious diseases, tumor markers and animal diseases. Many of our products have been approved by Chinese SFDA., Boson Biotech's mission is to provide the affordable high quality products to help fighting diseases and illicit substance abuse., More, , Less, 

See the catalogue

Production Capacity

Export Year

2007-03-01

Main Markets

North America, South America, Eastern Europe, Southeast Asia, Africa, Oceania, Mid East, Eastern Asia, Western Europe

R&D Capacity

OEM, Own Brand()

Factory Address

90-94 Tianfeng Road, Jimei North Industrial Park, Xiamen, Fujian, China

No. of R&D Staff

11-20 People

Terms of Payment

LC, T/T, D/P, PayPal, Western Union, Small-amount payment, Money Gram

Average Lead Time

Peak Season Lead Time: within 15 workdays, Off Season Lead Time: within 15 workdays

Export Percentage

41%~50%

Import & Export Mode

Have Own Export License

Annual Export Revenue

>100 million USD

No. of Production Lines

Number of Foreign Trading Staff

4~10 People

International Commercial Terms(Incoterms)

FOB, CFR, CIF, FAS, DDP, DAP, CIP, CPT, FCA, EXW

Rapid Test Manufacturer, in Vitro Diagnostics, Drugs of Abuse Supplier - Xiamen Boson Biotech Co., Ltd.

Rapid Test Manufacturer, in Vitro Diagnostics, Drugs of Abuse Supplier - Xiamen Boson Biotech Co., Ltd.

Production Capacity

Trade terms

Management certification

Production Capacity

Trade terms

Management certification